CAR T-cell therapy uses the patient's own T-cells to attack and kill cancer cells, and is highly effective in stopping advanced cancers. The FDA has approved CAR T-cell therapy to treat several types of non-Hodgkin's lymphoma, multiple myeloma, and acute lymphoblastic leukemia. Research trials are underway exploring treating cancers of the breast, colon, brain, and lungs.
Donations will help us purchase expensive equipment and expand space at St. Luke’s to offer this valuable cancer therapy. Our goal is to deliver all of a patient's CAR T-cell care in one outpatient clinic space, only sending patients to the hospital if they need hospitalization.